TruTag Technologies has named pharma veteran Les Leff of Polar Investment Fund to its board of directors.
Leff is also a former co-owner and executive vice president of pharma sales and consultancy group JWS Delavau and previously was president of AccuCorp, a contract manufacturer of vitamins, minerals and over-the-counter pharmaceuticals. He has also served in a variety of senior technical liaison, plant management, union negotiation and Food and Drug Administration negotiation roles.
“Les is a seasoned pharmaceutical executive with many years of leadership in this dynamic marketplace,” said Michael Bartholomeausz, TruTag’s CEO.
“He brings a wealth of experience and operational knowledge that will help push TruTag forward as we expand our footprint in improving the safety, traceability, and authenticity of pharmaceuticals.”